Sionna Therapeutics Inc. (SION) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sionna Therapeutics Inc.

    NASDAQ: SION · Real-Time Price · USD
    28.65
    1.15 (4.18%)
    At close: Sep 26, 2025, 1:13 PM

    Sionna Therapeutics Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a
    Operating Income
    		 -70.56M -50.33M -41.37M
    Interest Income
    		 8.17M 2.77M 1.13M
    Pretax Income
    		 -61.69M -47.26M -40.24M
    Net Income
    		 -61.69M -47.26M -40.24M
    Selling & General & Admin
    		 12.6M 9.71M 6.77M
    Research & Development
    		 57.29M 40.63M 34.6M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 70.56M 50.33M 41.37M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 70.56M 50.33M 41.37M
    Income Tax Expense
    		 n/a n/a n/a
    Shares Outstanding (Basic)
    		 42.44M 27.8M 17.33M
    Shares Outstanding (Diluted)
    		 42.44M 27.8M 17.33M
    EPS (Basic)
    		 -1.45 -1.7 -2.32
    EPS (Diluted)
    		 -15.99 -1.7 -2.32
    EBITDA
    		 -69.89M -49.75M -41.25M
    EBIT
    		 -70.56M -50.33M -41.37M
    Depreciation & Amortization
    		 668K 583K 122K

    Add to Watchlist